The percentage of men (75%) was stable in time. In STEMI, women were significantly older than men (median age 74 years vs 60 years; p<0.001), they were more likely to have hypertension (60% vs 40%; p<0.001) and diabetes (20% vs 15%; ns) but less likely to be active smokers (22% vs 45%, p<0.001). 45% of them had a body mass index (BMI) <25 against 36% of men. One year follow-up showed an equivalent prescription treatment in men and women for betablockers (95% of beta-blockers in women vs 93% of me), antiplatelet agents (99% vs 100%) and statins (96% vs 98%).
Prescription of angiotensin converting enzyme inhibitors was lower in women (87% of women vs. 94% of men (p<0.01)). Women presented more intolerance than men (10.5% vs 5%). 28% of women underwent a cardiac rehabilitation program vs 48% of men (p<0.001), 33% of them were physically active vs 56% of men (p<0.001). 72% of women have benefited from lipid and glucose control vs 78% of men (p<0.05). Their diet was described as more balanced (79% vs 73%; ns). In 94% of cases, the GP was in contact with the patient’s cardiologist.
Some studies suggest a relationship to disease prevention and gender. We found some differences to the detriment of women regarding cardiac rehabilitation and physical activity. A thorough study of a larger cohort is needed. Continuous information of health professionals on the risk of gender bias should be pursued.